Endurant Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-44,561
| Closed | -$5.25M | – | 59 |
|
|
2022
Q1 | $5.25M | Buy |
+44,561
| New | +$5.25M | 1.38% | 18 |
|
|
2018
Q4 | – | Sell |
-11,418
| Closed | -$663K | – | 60 |
|
|
2018
Q3 | $663K | Buy |
+11,418
| New | +$663K | 0.29% | 58 |
|
|
2018
Q1 | – | Sell |
-36,648
| Closed | -$1.38M | – | 77 |
|
|
2017
Q4 | $1.38M | Buy |
36,648
+1,800
| +5% | +$67.6K | 0.42% | 54 |
|
|
2017
Q3 | $1.27M | Sell |
34,848
-32,100
| -48% | -$1.17M | 0.38% | 61 |
|
|
2017
Q2 | $2.64M | Buy |
66,948
+3,000
| +5% | +$118K | 0.75% | 39 |
|
|
2017
Q1 | $2.01M | Buy |
63,948
+32,148
| +101% | +$1.01M | 0.64% | 46 |
|
|
2016
Q4 | $993K | Buy |
+31,800
| New | +$993K | 0.41% | 50 |
|
|
2015
Q4 | – | Sell |
-16,200
| Closed | -$384K | – | 81 |
|
|
2015
Q3 | $384K | Sell |
16,200
-50,400
| -76% | -$1.19M | 0.13% | 70 |
|
|
2015
Q2 | $1.58M | Buy |
+66,600
| New | +$1.58M | 0.47% | 53 |
|